IXICO plc
PHYOF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,488 | $4,672 | $2,530 | $5,778 |
| - Cash | $3,537 | $5,010 | $1,787 | $2,532 |
| + Debt | $179 | $275 | $314 | $323 |
| Enterprise Value | $1,130 | -$63 | $1,057 | $3,569 |
| Revenue | – | $3,208 | $3,228 | $2,538 |
| % Growth | – | -0.6% | 27.2% | – |
| Gross Profit | – | $1,590 | $1,561 | $1,020 |
| % Margin | – | 49.6% | 48.4% | 40.2% |
| EBITDA | – | -$721 | -$302 | -$1,347 |
| % Margin | – | -22.5% | -9.4% | -53.1% |
| Net Income | – | -$958 | -$588 | -$1,413 |
| % Margin | – | -29.9% | -18.2% | -55.7% |
| EPS Diluted | – | -0.011 | -0.012 | -0.029 |
| % Growth | – | 9% | 58.2% | – |
| Operating Cash Flow | – | -$171 | -$530 | -$1,171 |
| Capital Expenditures | – | -$22 | -$10 | -$24 |
| Free Cash Flow | – | -$193 | -$540 | -$1,195 |